|
1
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carey L, Winer E, Viale G, Cameron D and
Gianni L: Triple-negative breast cancer: Disease entity or title of
convenience? Nat Rev Clin Oncol. 7:683–692. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Foulkes WD, Smith IE and Reis-Filho JS:
Triple-negative breast cancer. N Engl J Med. 363:1938–1948. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fulford LG, Reis-Filho JS, Ryder K, Jones
C, Gillett CE, Hanby A, Easton D and Lakhani SR: Basal-like grade
III invasive ductal carcinoma of the breast: Patterns of metastasis
and long-term survival. Breast Cancer Res. 9:R42007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dent R, Hanna WM, Trudeau M, Rawlinson E,
Sun P and Narod SA: Pattern of metastatic spread in triple-negative
breast cancer. Breast Cancer Res Treat. 115:423–428. 2009.
View Article : Google Scholar
|
|
6
|
Ismail-Khan R and Bui MM: A review of
triple-negative breast cancer. Cancer Control. 17:173–176.
2010.PubMed/NCBI
|
|
7
|
Dent R, Trudeau M, Pritchard KI, Hanna WM,
Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P and Narod SA:
Triple-negative breast cancer: Clinical features and patterns of
recurrence. Clin Cancer Res. 13:4429–4434. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cleator S, Heller W and Coombes RC:
Triple-negative breast cancer: Therapeutic options. Lancet Oncol.
8:235–244. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yoshiko Y and Aubin JE: Stanniocalcin 1 as
a pleiotropic factor in mammals. Peptides. 25:1663–1669. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chang AC, Jellinek DA and Reddel RR:
Mammalian stanniocalcins and cancer. Endocr Relat Cancer.
10:359–373. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Olsen HS, Cepeda MA, Zhang QQ, Rosen CA,
Vozzolo BL and Wagner GF: Human stanniocalcin: A possible hormonal
regulator of mineral metabolism. Proc Natl Acad Sci USA.
93:1792–1796. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stasko SE and Wagner GF: Stanniocalcin
gene expression during mouse urogenital development: A possible
role in mesenchymal-epithelial signalling. Dev Dyn. 220:49–59.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang KZ, Westberg JA, Paetau A, von
Boguslawsky K, Lindsberg P, Erlander M, Guo H, Su J, Olsen HS and
Andersson LC: High expression of stanniocalcin in differentiated
brain neurons. Am J Pathol. 153:439–445. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tamura S, Oshima T, Yoshihara K, Kanazawa
A, Yamada T, Inagaki D, Sato T, Yamamoto N, Shiozawa M, Morinaga S,
et al: Clinical significance of STC1 gene expression in patients
with colorectal cancer. Anticancer Res. 31:325–329. 2011.PubMed/NCBI
|
|
15
|
Fang Z, Tian Z, Luo K, Song H and Yi J:
Clinical significance of stanniocalcin expression in tissue and
serum of gastric cancer patients. Chin J Cancer Res. 26:602–610.
2014.PubMed/NCBI
|
|
16
|
Fujiwara Y, Sugita Y, Nakamori S, Miyamoto
A, Shiozaki K, Nagano H, Sakon M and Monden M: Assessment of
Stanniocalcin-1 mRNA as a molecular marker for micrometastases of
various human cancers. Int J Oncol. 16:799–804. 2000.PubMed/NCBI
|
|
17
|
Paulitschke V, Kunstfeld R, Mohr T, Slany
A, Micksche M, Drach J, Zielinski C, Pehamberger H and Gerner C:
Entering a new era of rational biomarker discovery for early
detection of melanoma metastases: Secretome analysis of associated
stroma cells. J Proteome Res. 8:2501–2510. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Law AY, Lai KP, Lui WC, Wan HT and Wong
CK: Histone deacetylase inhibitor-induced cellular apoptosis
involves stan-niocalcin-1 activation. Exp Cell Res. 314:2975–2984.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lai KP, Law AY, Yeung HY, Lee LS, Wagner
GF and Wong CK: Induction of stanniocalcin-1 expression in
apoptotic human nasopharyngeal cancer cells by p53. Biochem Biophys
Res Commun. 356:968–975. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yeung HY, Lai KP, Chan HY, Mak NK, Wagner
GF and Wong CK: Hypoxia-inducible factor-1-mediated activation of
stanniocalcin-1 in human cancer cells. Endocrinology.
146:4951–4960. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jeon M, Lee J, Nam SJ, Shin I, Lee JE and
Kim S: Induction of fibronectin by HER2 overexpression triggers
adhesion and invasion of breast cancer cells. Exp Cell Res.
333:116–126. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Du YZ, Gu XH, Li L and Gao F: The
diagnostic value of circulating stanniocalcin-1 mRNA in non-small
cell lung cancer. J Surg Oncol. 104:836–840. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chang AC, Doherty J, Huschtscha LI,
Redvers R, Restall C, Reddel RR and Anderson RL: STC1 expression is
associated with tumor growth and metastasis in breast cancer. Clin
Exp Metastasis. 32:15–27. 2015. View Article : Google Scholar
|
|
24
|
Liu G, Yang G, Chang B, Mercado-Uribe I,
Huang M, Zheng J, Bast RC, Lin SH and Liu J: Stanniocalcin 1 and
ovarian tumorigenesis. J Natl Cancer Inst. 102:812–827. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ismail RS, Baldwin RL, Fang J, Browning D,
Karlan BY, Gasson JC and Chang DD: Differential gene expression
between normal and tumor-derived ovarian epithelial cells. Cancer
Res. 60:6744–6749. 2000.PubMed/NCBI
|
|
26
|
Law AY, Ching LY, Lai KP and Wong CK:
Identification and characterization of the hypoxia-responsive
element in human stanniocalcin-1 gene. Mol Cell Endocrinol.
314:118–127. 2010. View Article : Google Scholar
|
|
27
|
Ozes ON, Mayo LD, Gustin JA, Pfeffer SR,
Pfeffer LM and Donner DB: NF-kappaB activation by tumour necrosis
factor requires the Akt serine-threonine kinase. Nature. 401:82–85.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sizemore N, Leung S and Stark GR:
Activation of phosphatidylinositol 3-kinase in response to
interleukin-1 leads to phosphorylation and activation of the
NF-kappaB p65/RelA subunit. Mol Cell Biol. 19:4798–4805. 1999.
View Article : Google Scholar : PubMed/NCBI
|
